Triheptanoin for the treatment of long‐chain fatty acid oxidation disorders: Final results of an open‐label, long‐term extension studyJerry Vockley, Antonio Nino Ramirez, Amarilis Sanchez‐Valle et al.|Journal of Inherited Metabolic Disease|2023Cited by 21
IMPROVEMENTS IN MAJOR CLINICAL EVENTS IN CHILDREN TREATED WITH TRIHEPTANOIN FOR LONG-CHAIN FATTY ACID OXIDATION DISORDERS (LC-FAOD)Kathryn Ray, Jerry Vockley, Laura Rosa Pisani et al.|Molecular Genetics and Metabolism|2022Cited by 0